On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayFeb 03, 2023 1:26 pm

QualityStocksNewsBreaks – CubCrafters Inc.’s Long Relationship with US Government Demonstrates Its Exceptional Abilities in Backcountry Aviation

CubCrafters is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “For close to two decades now, CubCrafters has supplied aircraft to various U.S. Federal Government agencies, including the U.S. Air Force Research Laboratory, the U.S. Air Force Flight Academy, the U.S. Department of Agriculture (‘USDA’), the U.S. Department of Homeland Security (‘DHS’), and the U.S. Department of the Interior (‘DOI’)… The consistent appeal of CubCrafters’ aircraft stems from the fact that they have significantly lower operational costs compared to helicopters and other more expensive fixed-wing aircraft… In addition to the lower operational cost, CubCrafters…

Continue Reading

FridayFeb 03, 2023 1:03 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Helping Companies to Affordably Transition from Dependence on Carbon Fuel

Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled distributed energy solutions company, foresees exciting new opportunities available thanks to the government’s emphasis on driving the country toward a future free of its dependence on carbon fuel and otherwise inefficient utilities. “Correlate is focused on helping companies that develop and rent out commercial building properties succeed at acquiring solar, cogeneration, energy storage, and electric vehicle infrastructure, and doing so in a way that is both affordable and profit-improving for the client,” a recent article reads. “The company’s subsidiaries work harmoniously to analyze clients’ utilities performance. Correlate then provides recommendations for improvements based…

Continue Reading

FridayFeb 03, 2023 12:33 pm

QualityStocksNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Distinctive Solutions Positioned to Transform the Way Patients, Doctors Detect Heart Attacks

HeartBeam (NASDAQ: BEAT) is a cardiac technology company that is leading the way in identifying heart attacks by developing a personal, portable and easy-to-use heart-attack detection solution. “The company has two patented products in development: HeartBeam AIMI(TM), software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack, and HeartBeam AIMIGo(TM), the first and only credit-card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system to facilitate remote heart-attack detection… The company anticipates receiving regulatory approval soon for the use of the HeartBeam…

Continue Reading

FridayFeb 03, 2023 12:00 pm

QualityStocksNewsBreaks – Why McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Is ‘One to Watch’

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. In addition, the company has a large exposure to copper through its subsidiary McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 9th largest undeveloped copper resource in the world. “McEwen Mining is a 68% shareholder in McEwen Copper, holder of a 100% interest in the Los Azules copper project in San Juan, Argentina… Its current copper resources are estimated at 10.2 billion pounds at a grade of 0.48% Cu (Indicated category) and an additional 19.3…

Continue Reading

FridayFeb 03, 2023 11:50 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Pleased with Early Results from Global Clinical Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently reported that 67 patients have enrolled in the potentially pivotal phase 2 globally cited clinical study comparing drug candidate Berubicin’s effectiveness to second-line standard-of-care chemotherapy drug Lomustine. “The  company plans to have more than 200 patients participate in the clinical trial on a 2:1 randomization schema between those receiving Berubicin and those receiving Lomustine… Berubicin’s performance in an initial safety trial conducted by another company in 2006 resulted in apparent life extension for some patients and complete remission for one patient who, unusually, survives nearly 17 years later. The ongoing study now seeks to demonstrate…

Continue Reading

FridayFeb 03, 2023 9:45 am

SideChannel Inc. (SDCH) Notes Importance of Cybersecurity for Cannabis Industry Operational Technology as Hybrid Work Models Expand

SideChannel Inc. is a cybersecurity services and technology provider that assists small- to medium-sized businesses unable to budget for full time on-site cybersecurity staffing SideChannel supplies virtual chief information security officer (“vCISO”) expert services on a contract basis at an expense that is lower than the cost of regular full-time CISO staffing SideChannel CEO noted the importance of SMB network security protocols in a recent CISOlife podcast, specifically in regard to cannabis operations that are often small and cash-rich without significant cyber protections in place Growing economic uncertainty is expected to increase the number of SMBs that may fall under…

Continue Reading

FridayFeb 03, 2023 9:00 am

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) – Los Azules Project Could Be World’s Next Copper Unicorn

Both gold and copper have seen significant increases in market value in recent months, and copper is forecast to be one of the best-performing of all commodities in 2023, based upon increased demand and projected shortages McEwen Mining is a majority shareholder of McEwen Copper, which owns the Los Azules copper deposit in Argentina, one of the largest undeveloped copper projects in the world McEwen Copper plans to update its PEA (preliminary economic assessment) during Q1 2023, follow with IPO during Q2, and complete the Feasibility Study in 2024 Historically, gold has been a staple in investment portfolios due to…

Continue Reading

ThursdayFeb 02, 2023 3:11 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) to Present at BIO CEO & Investor Conference

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced that its CEO Amir Reichman will present at the BIO CEO & Investor Conference. The event is slated to take place in New York from Feb. 6-9, 2023. Reichman’s presentation, scheduled to begin at 4:15 p.m. ET on Feb. 6, will focus on recent successful preclinical in vivo results of BiondVax’s innovative inhaled COVID-19 treatment. The presentation will also cover additional pipeline plans, including nanosized VHH-antibodies (“NanoAbs”) for the treatment of autoimmune diseases, such…

Continue Reading

ThursdayFeb 02, 2023 1:57 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partners with Loop Global, Menzies Aviation on LAX Pilot Program

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is collaborating with Menzies Aviation and Loop Global Inc. on a pilot program at the Los Angeles International Airport; the program involves Mullen’s Class 1 EV cargo vans. The world’s largest aviation services company, Menzies operates in 250-plus airports in 58 countries, providing ground, air cargo and fuel services to commercial airports and airlines. Menzies is piloting Mullen Automotive electric vans and Loop Global charging infrastructure across its operations at LAX; the program is part of Menzies commitment to identify innovative solutions as it works to become carbon neutral by…

Continue Reading

ThursdayFeb 02, 2023 1:26 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Elevate Drug Delivery Across Blood-Brain Barrier by ~1,900%

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed its patented DehydraTECH(TM) technology, which is designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. “DehydraTECH increases effectiveness and improves how these ingredients enter the bloodstream. Benefits of DehydraTECH include: improved speed of onset, with effects felt in minutes; increased bioavailability, with more of the drug delivered into the bloodstream; increased brain absorption, with testing suggesting up to 10x improvement; and improved drug potency, with more of the ingested product made available in the bloodstream requiring lower dosages,” a recent article reads. “Animal studies…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered